122 related articles for article (PubMed ID: 19446866)
1. CD83 polymorphisms and cervical cancer risk.
Yu KJ; Rader JS; Borecki I; Zhang Z; Hildesheim A
Gynecol Oncol; 2009 Aug; 114(2):319-22. PubMed ID: 19446866
[TBL] [Abstract][Full Text] [Related]
2. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
Zhang Z; Borecki I; Nguyen L; Ma D; Smith K; Huettner PC; Mutch DG; Herzog TJ; Gibb RK; Powell MA; Grigsby PW; Massad LS; Hernandez E; Judson PL; Swisher EM; Crowder S; Li J; Gerhard DS; Rader JS
Cancer Res; 2007 Dec; 67(23):11202-8. PubMed ID: 18056445
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.
Bodelon C; Madeleine MM; Johnson LG; Du Q; Malkki M; Petersdorf EW; Schwartz SM
Gynecol Oncol; 2012 Mar; 124(3):525-8. PubMed ID: 22134374
[TBL] [Abstract][Full Text] [Related]
4. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
5. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
Zelmanowicz Ade M; Schiffman M; Herrero R; Goldstein AM; Sherman ME; Burk RD; Gravitt P; Viscidi R; Schwartz P; Barnes W; Mortel R; Silverberg SG; Buckland J; Hildesheim A
Int J Cancer; 2005 Sep; 116(4):599-605. PubMed ID: 15818615
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry.
Yu KJ; Bashirova A; Madeleine MM; Cheng J; Johnson LG; Schwartz SM; Carrington M; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2504-8. PubMed ID: 18006945
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.
Hussain SK; Madeleine MM; Johnson LG; Du Q; Galloway DA; Daling JR; Malkki M; Petersdorf EW; Schwartz SM
Int J Cancer; 2013 Jul; 133(1):201-13. PubMed ID: 23280621
[TBL] [Abstract][Full Text] [Related]
8. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population.
Łaźniak S; Lutkowska A; Wareńczak-Florczak Ż; Sowińska A; Tsibulski A; Roszak A; Sajdak S; Jagodziński PP
Arch Gynecol Obstet; 2018 May; 297(5):1285-1292. PubMed ID: 29525942
[TBL] [Abstract][Full Text] [Related]
9. [Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].
Li H; Zhou YF; Guo HY; Sun T; Zhang WH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):681-4. PubMed ID: 22340049
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.
Shi TY; Zhu ML; He J; Wang MY; Li QX; Zhou XY; Sun MH; Shao ZM; Yu KD; Cheng X; Wu X; Wei Q
Hum Genet; 2013 Mar; 132(3):301-12. PubMed ID: 23180271
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
Qi T; Wang Q; Zheng L; Yang HL; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms and haplotypes of carbonic anhydrase 9 can predict invasive squamous cell carcinoma of uterine cervix.
Shen HP; Hsiao YH; Yang SF; Liu YF; Ko JL; Wang PH
Int J Med Sci; 2018; 15(6):587-594. PubMed ID: 29725249
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.
Bodelon C; Madeleine MM; Johnson LG; Du Q; Galloway DA; Malkki M; Petersdorf EW; Schwartz SM
Int J Cancer; 2014 Jan; 134(2):437-44. PubMed ID: 23824834
[TBL] [Abstract][Full Text] [Related]
15. [Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer].
Li H; Guo HY; Sun T; Zhou YF; Lin DX; Zhang WH; Qiao J
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):38-41. PubMed ID: 19538867
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
17. Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women.
Thakur N; Singhal P; Mehrotra R; Bharadwaj M
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872409
[No Abstract] [Full Text] [Related]
18. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
19. A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.
Wu S; Wang S; Fu Y; Tang W; Jin H; Meng Q; Zhang C; Cui M; Cao X; Li X; Zhang Z; Chen R
Int J Cancer; 2017 Feb; 140(4):756-763. PubMed ID: 27790710
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.
Wongpratate M; Ishida W; Phuthong S; Natphopsuk S; Ishida T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):243-248. PubMed ID: 31983191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
